METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Clinical trials for METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to outsmart Hard-to-Treat colorectal cancer
Disease control Recruiting nowThis early-stage study tests a combination of two drugs, abemaciclib and 5-fluorouracil, in people with advanced colorectal cancer that has spread and no longer responds to standard treatments. The main goals are to find the safest dose and understand side effects. About 39 adult…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:39 UTC
-
New hope for Tough-to-Treat colon cancer: immunotherapy combo trial launches
Disease control Recruiting nowThis study tests a combination of two immunotherapy drugs (nadunolimab and toripalimab) in people with advanced colorectal cancer that has stopped responding to standard chemotherapy. The goal is to see if this treatment can shrink tumors and control the disease. About 24 partici…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Dan Feng • Aim: Disease control
Last updated May 26, 2026 09:30 UTC
-
New drug duo aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a combination of two drugs, temozolomide and M1774, in adults with advanced solid tumors that have spread. The goal is to find the safest dose and see if the combo can shrink or slow tumor growth better than temozolomide alone. About 58 participants will take par…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC